个人介绍

姓名： 姚伟

职称：讲师

研究方向：神经精神疾病发病机制及治疗药物研究

电子邮箱：weiyao@jnu.edu.cn

个人简介：（限200字）

讲师，医学博士，硕士生导师。2017年4月毕业于日本千叶大学医学院神经科学专业，获得博士学位，博士毕业后就职于日本东京医科齿科大学神经内科，从事助理研究员，主要研究阿尔茨海默病发病机制以及新药研发相关基础和临床工作。2019年12月进入暨南大学中医学院工作。主要从事抑郁症发病机制、中药及其有效活性成分防治抑郁症以及潜在治疗药物的研发。相关研究成果在Molecular Psychiatry、Translational Psychiatry、Molecular Therapy Nucleic Acids、Aging cell等国际高水平杂志发表SCI论文34篇，其中以（共）第一/通讯作者发表SCI论文12篇，h-index为27。主持国家级项目和省级课题各1项。主讲《医学科研方法概论》本科课程。

教学/科研成果

1. Lin Z, Huang L, Cao Q, Luo H, Yao W*, Zhang JC*. Inhibition of abnormal C/EBPβ/α-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology. Aging cell. 2023, 23: e13958.

2. Luo H, Zhang C, He L, Lin Z, Zhang JC, Qi Q*, Chen JX*, Yao W*. 18β‐glycyrrhetinic acid ameliorates MPTP‐induced neurotoxicity in mice through activation of microglial anti‐inflammatory phenotype.Psychopharmacology (Berl). 2023, 240(9):1947-1961.

3. He L#, Zheng Y#, Huang L#, Ye J, Ye Y, Luo H, Chen X, Yao W*, Chen J*, Zhang JC*. Nrf2 regulates the arginase 1+ microglia phenotype through the initiation of TREM2 transcription, ameliorating depression-like behavior in mice. Transl Psychiatry. 2022,12(1): 459.

4.Zhang JC*, Yao W, and Hashimoto K*. Arketamine, a new rapid-acting antidepressant: A historical review and future directions. Neuropharmacology. 2022. 218:109219.

5.Cao QQ #, Luo SL#, Yao W#, Qu YG, Wang NB, Hong J, Murayama S, Zhang ZT, Chen JX, Hashimoto K*, Qi Qi*, and Zhang JC*. Suppression of abnormal a-synuclein expression by activation of BDNF transcription ameliorates Parkinson’s disease-like pathology. Molecular Therapy Nucleic Acids. 2022. 29:1-15.

6. Huang LX#, He LJ#, Ma RJ#, Ding WZ, Zhou C, Lin S, Zhang JC, Chen JX* and Yao W*. The role of MeCP2 and the BDNF/TrkB signaling pathway in the stress resilience of mice subjected to CSDS. Psychopharmacology (Berl). 2022. 239(9):2921-2929.

7. Yao W#, Cao QQ#, Luo SL#, He LJ, Yang C, Chen JX, Qi Q*, Hashimoto K*, and Zhang JC*. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine, Molecular Psychiatry. 2022, 27(3): 1618–1629.

8. Yao W#; Lin S#; Su J; Cao QQ; Chen YY; Chen JX; Zhang ZT; Hashimoto K*; Qi Q*; Zhang JC*. Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents, Transl Psychiatry. 2021; 11: 140.

9. Yao W, Zhang JC, Ishima T, Ren Q, Yang C, Dong C, Ma M, Saito A, Honda T, Hashimoto K. Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression. Eur J Pharmacol. 2016, pii: S0014-2999(16)30677-X.

10. Yao W, Zhang JC, Dong C, Zhuang C, Hirota S, Inanaga K, Hashimoto K. Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav 2015, 3(136):7-12

学术兼职

“iMeta”青年编委